Related Experiment Videos
The risk of bilirubin encephalopathy in neonatal hyperbilirubinemia
1Department of Pediatrics, Cukurova University Faculty of Medicine, Adana.
Insights
High free bilirubin levels in newborns indicate a significant risk of bilirubin encephalopathy. Monitoring free bilirubin is crucial for managing hyperbilirubinemia and preventing toxicity in infants.
Area of Science:
- Neonatal Medicine
- Pediatric Neurology
- Biochemistry
Background:
- Neonatal jaundice is common, with a risk of bilirubin encephalopathy during hyperbilirubinemia.
- Unconjugated hyperbilirubinemia poses a potential threat to newborns.
Purpose of the Study:
- To investigate the relationship between serum free bilirubin levels and signs of bilirubin encephalopathy in newborn infants.
- To determine the clinical significance of free bilirubin measurements in managing hyperbilirubinemia.
Main Methods:
- Studied 83 newborn infants (40 premature, 43 mature) with unconjugated hyperbilirubinemia.
- Conducted physical examinations to identify signs of bilirubin encephalopathy.
- Measured serum free and total bilirubin levels.
Main Results:
- 12 out of 13 infants with serum free bilirubin > 0.1 mg/dl showed signs of encephalopathy.
- No infants with serum free bilirubin < 0.1 mg/dl exhibited signs of encephalopathy.
- A positive correlation exists between serum total and free bilirubin, but the threshold for free bilirubin appearance is unclear.
Conclusions:
- Serum free bilirubin levels exceeding 0.1 mg/dl are strongly associated with bilirubin encephalopathy in newborns.
- Serial free bilirubin monitoring is valuable for managing hyperbilirubinemia in high-risk infants.
- Early detection and management of elevated free bilirubin are critical for preventing neurological damage.
Abstract:
Jaundice is the most common and one of the most annoying problems that can occur in the newborn. Although most jaundiced infants recover without any serious problem, there is always a risk of bilirubin encephalopathy during the period of hyperbilirubinemia. The relationship between encephalopathy and serum free bilirubin levels was investigated in 83 newborn infants (40 premature, 43 mature) with unconjugated hyperbilirubinemia. A complete physical examination was done in all patients, and signs of bilirubin encephalopathy were noted if present. The serum free bilirubin level exceeded 0.1 mg/dl in 13 infants, and 12 of them showed signs of encephalopathy. On the other hand, none of the infants whose serum free bilirubin levels were below 0.1 mg/dl showed signs of encephalopathy. Although there is a significant positive correlation between serum total and free bilirubin levels, it is not clear at what total bilirubin level free bilirubin will appear. Serial determinations of free bilirubin appear to be more helpful in the management of hyperbilirubinemia in infants with an increased risk of bilirubin toxicity.